[PDF] Top 20 Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome

... the endothelial lining ...the cell is seen when ECs are incubated with FFs from group I patients ...entire cell, with re- sulting stress fiber ... See full document

... receptors seem to play a key role in this physiological process [4-7]. These observations are strengthened by the findings that the probability of developing OHSS corre- lates with the concentration of VEGF in ... See full document

... real role of the different types of VEGF ...on vascular permeability, and can also act to prevent and treat OHSS However, other studies have associated the lower serum levels of soluble VEGFR-2 with OHSS ... See full document

... VEGF’s protective effects are associated with enhanced production of TSP1. Finally, we sought to determine the potential mechanism through which the endothelium might contribute to epithelial homeostasis. Endo- thelial ... See full document

... in endothelial cells of follicles has been demonstrated by in situ hybridization [13] and immunocytochemistry ...[14]. Ovarian VEGF gene expres- sion was found to increase significantly following hCG ... See full document

... breast-cancer cell line (MDA-MB-231) with recombinant IGFBP7 protein induced G 1 cell-cycle arrest and senescence, as indicated by cell-cycle analysis and β -galactosidase staining, ...IGFBP7-induced ... See full document

... new vascular structures in the villous stroma ...dual role in the placenta, acting on both angiogenesis and trophoblast function during placental ...increased endothelial cell proliferation ... See full document

... the Vascular Endothelial Growth Factor, a protein which plays a major role in ...tumor growth and metastasis, as the newly formed blood vessels facilitate the transfer of the ... See full document

... Epithelial ovarian cancer (EOC) is one of the most lethal gynaecologic malignancies with an increasing incidence worldwide; there is an increasing need for the identification of novel prognostic biomarkers in EOC ... See full document

... Vascular endothelial growth factor: Vascular Endothelial Growth Factor (VEGF) is a 45 kDa heparin binding homodimeric glycoprotein that plays an important ... See full document

... anti-vascular endothelial growth factor therapy) remains uncertain, which has been the focus of studies on the management of epithelial ovarian cancer ... See full document

... of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell ... See full document

... kidney cell line [HEK-293, CRL-1573; American Type Culture Collection (ATCC), Manassas, VA, USA] and rat cardio- myocyte cell line (H9c2, CRL-1446; ... See full document

... in endothelial cells and mediating angio- genesis through the delivery of 14-3-3 ζ , which induces YAP phosphorylation to in fl uence wnt4 signaling ...stem cell-derived exosomes contain mRNAs, miRNAs, ... See full document

... angiogenic factor [9,10]. Understanding of the role of these angiogenic factors in CHD could be impor- tant in medical or surgical management of such cases ... See full document

... The study indicates that it is not enough to base the algorithm of clinical assessment on physical parameters, such as the size and num- ber of neoplastic foci, pathological data inform- ing on the microvascular invasion ... See full document

... VEGF: vascular endothelial growth factor; PlGF: placental growth factor; VEGFR: vascular endothelial growth factor receptor; RPE: retinal pigment ... See full document

... We further investigated the prognostic role of SNPs on OS. As Figure 2 shows, the following polymorphisms were significantly correlated with a better OS, although they did not achieve median survival. Patients ... See full document

... When imatinib, the first available signaling pathway in- hibitor, was introduced in CML, it was regarded as a highly BCR-ABL-specific drug. With both an increase in the number of treated patients and the development of ... See full document

... The study was conducted between August 1997 and July 1999 at the Hospital for Children and Adolescents, University of Hel- sinki (Helsinki, Finland). The study protocol was approved by the institutional review boards, ... See full document